NASDAQ:ARDS

Aridis Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

ARDS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 18, 2021 Sep 2021 $-0.49 $-0.55 $-0.65
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 18, 2021 Sep 2021 $220.00K $33.00K $0.00

Aridis Pharmaceuticals, Inc's next earnings date is Thursday, Nov 18, 2021 for the fiscal quarter ending Sep 2021.

ARDS Earnings Date & History Chart

ARDS Earnings & Revenue Forecast

ARDS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.49 $-0.58 $-0.37
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-2.16 $-2.30 $-1.94
Dec 2022 4 $-1.36 $-3.56 $1.41

ARDS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.49 $-0.59 $-0.60
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.16 $-2.57 $-2.55
Dec 2022 0 / 0 $-1.36 $-0.63 $-0.52

ARDS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $800.00K $0.00 $1.70M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $1.14M $30.00K $2.50M
Dec 2022 4 $20.12M $0.00 $78.50M

ARDS Earnings Date & Revenue History

ARDS Earnings History

|
Show More
Show More

ARDS Revenue History

|
Show More
Show More

Aridis Pharmaceuticals, Inc Next Earnings Date & Report

ARDS Next Earnings Date & Report Preview: Sep 2021 (FQ)

ARDS's next earnings date is Thursday, Nov 18, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Aridis Pharmaceuticals, Inc's next quarterly earnings is $-0.49, with a low EPS estimation of $-0.54, and a high estimation of $-0.42.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.49, the last 2 month trend is $-0.64, and the 3 month trend is $-0.63.

Based on 4 analysts, the average revenue estimation is $220.00K, with a low revenue estimation of $0.00, and a high estimation of $500.00K.

Aridis Pharmaceuticals, Inc Previous Earnings Dates & Reports

ARDS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aridis Pharmaceuticals, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

ARDS's earnings per share (EPS) was $-0.55, beating the consensus analysts forecast of $-0.59 by 6.79%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -28.18%, and lower than the same period a year before (Jun 2020) by 17.66%.

Revenues were $33.00K, better than the forecast of $33.00K by 0.00%, up by 371.43% from the previous quarter , and down by -96.70% from the same period last year.

The company reported a net income of $-5.49M.

Free cash flow for the quarter was $-6.73M , compared to $-4.34M last quarter and $-5.23M a year before.

ARDS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aridis Pharmaceuticals, Inc's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

ARDS's earnings per share (EPS) was $-2.33, beating the consensus analysts forecast of $-2.44 by -4.51% , and higher than the previous year's EPS (Dec 2019) by -33.81%.

Revenues were $1.00K, worse than the forecast of $1.50M by -99.93%, and down by -99.90% from previous year's revenue.

The company reported a net income of $-22.33K.

Aridis Pharmaceuticals, Inc reported a free cash flow of $-20.84M for its fiscal year, compared to $-8.33M a year ago.